1. Home
  2. INCY vs WSO Comparison

INCY vs WSO Comparison

Compare INCY & WSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incyte Corp.

INCY

Incyte Corp.

HOLD

Current Price

$106.24

Market Cap

17.0B

Sector

Health Care

ML Signal

HOLD

Logo Watsco Inc.

WSO

Watsco Inc.

HOLD

Current Price

$371.53

Market Cap

14.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
INCY
WSO
Founded
1991
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
17.0B
14.1B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
INCY
WSO
Price
$106.24
$371.53
Analyst Decision
Buy
Hold
Analyst Count
21
8
Target Price
$96.79
$426.67
AVG Volume (30 Days)
2.2M
351.1K
Earning Date
02-09-2026
02-17-2026
Dividend Yield
N/A
3.20%
EPS Growth
3878.02
N/A
EPS
5.90
12.87
Revenue
$4,813,105,000.00
$7,414,495,000.00
Revenue This Year
$19.59
N/A
Revenue Next Year
$10.80
$3.74
P/E Ratio
$17.52
$29.09
Revenue Growth
18.09
N/A
52 Week Low
$53.56
$323.05
52 Week High
$112.29
$535.40

Technical Indicators

Market Signals
Indicator
INCY
WSO
Relative Strength Index (RSI) 57.76 61.86
Support Level $102.68 $346.48
Resistance Level $112.29 $381.70
Average True Range (ATR) 3.15 10.36
MACD 0.44 3.24
Stochastic Oscillator 58.73 77.34

Price Performance

Historical Comparison
INCY
WSO

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

About WSO Watsco Inc.

Watsco is the largest heating, ventilation, air conditioning, and refrigeration products distributor in North America. The company primarily operates in the United States (90% of revenue), with significant exposure in the Sun Belt states. Watsco also has operations in Canada (5% of sales) and Latin America (5% of sales). The company's customer base consists of more than 125,000 contractors that serve the replacement and new construction HVACR markets for residential and light commercial applications.

Share on Social Networks: